Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aerva lanata decoction
- Development stage
- Preclinical
- Lead developer
- Pooja Bhagavat Memorial Mahajana Education Centre
- Administration
- Oral
01
Overview
Aerva lanata decoction is a traditional Ayurvedic preparation derived from the aerial parts of the *Aerva lanata* plant. It is being investigated for its neuroprotective, anti-inflammatory, and antioxidant properties, particularly in the context of Parkinson's disease. In preclinical Drosophila models of Parkinson's disease, the decoction has demonstrated the ability to alleviate neuroinflammation, reduce oxidative stress (by lowering hydroperoxides and elevating glutathione levels), and restore cholinesterase activity, thereby normalizing locomotor and crawling dysfunction induced by toxins like rotenone.
- Other names
- Aerva lanata aerial parts decoctiondecoction of Aerva lanata
02
Targets
ButyrylcholinesteraseAcetylcholinesterase
Beyond the preview
Go deeper on Aerva lanata decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aerva lanata decoction.